Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Science in Medicine

  • 118 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 10
  • 11
  • 12
  • Next →
Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface
Kristy Red-Horse, … , Michael McMaster, Susan J. Fisher
Kristy Red-Horse, … , Michael McMaster, Susan J. Fisher
Published September 15, 2004
Citation Information: J Clin Invest. 2004;114(6):744-754. https://doi.org/10.1172/JCI22991.
View: Text | PDF

Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface

  • Text
  • PDF
Abstract

Trophoblasts, the specialized cells of the placenta, play a major role in implantation and formation of the maternal-fetal interface. Through an unusual differentiation process examined in this review, these fetal cells acquire properties of leukocytes and endothelial cells that enable many of their specialized functions. In recent years a great deal has been learned about the regulatory mechanisms, from transcriptional networks to oxygen tension, which control trophoblast differentiation. The challenge is to turn this information into clinically useful tests for monitoring placental function and, hence, pregnancy outcome.

Authors

Kristy Red-Horse, Yan Zhou, Olga Genbacev, Akraporn Prakobphol, Russell Foulk, Michael McMaster, Susan J. Fisher

×

Progress and problems in the biology, diagnostics, and therapeutics of prion diseases
Adriano Aguzzi, … , Mathias Heikenwalder, Gino Miele
Adriano Aguzzi, … , Mathias Heikenwalder, Gino Miele
Published July 15, 2004
Citation Information: J Clin Invest. 2004;114(2):153-160. https://doi.org/10.1172/JCI22438.
View: Text | PDF

Progress and problems in the biology, diagnostics, and therapeutics of prion diseases

  • Text
  • PDF
Abstract

The term “prion” was introduced by Stanley Prusiner in 1982 to describe the atypical infectious agent that causes transmissible spongiform encephalopathies, a group of infectious neurodegenerative diseases that include scrapie in sheep, Creutzfeldt-Jakob disease in humans, chronic wasting disease in cervids, and bovine spongiform encephalopathy in cattle. Over the past twenty years, the word “prion” has been taken to signify various subtly different concepts. In this article, we refer to the prion as the transmissible principle underlying prion diseases, without necessarily implying any specific biochemical or structural identity. When Prusiner started his seminal work, the study of transmissible spongiform encephalopathies was undertaken by only a handful of scientists. Since that time, the “mad cow” crisis has put prion diseases on the agenda of both politicians and the media. Significant progress has been made in prion disease research, and many aspects of prion pathogenesis are now understood. And yet the diagnostic procedures available for prion diseases are not nearly as sensitive as they ought to be, and no therapeutic intervention has been shown to reliably affect the course of the diseases. This article reviews recent progress in the areas of pathogenesis of, diagnostics of, and therapy for prion diseases and highlights some conspicuous problems that remain to be addressed in each of these fields.

Authors

Adriano Aguzzi, Mathias Heikenwalder, Gino Miele

×

Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Robert W. Schrier, … , Brian Poole, Amit Mitra
Robert W. Schrier, … , Brian Poole, Amit Mitra
Published July 1, 2004
Citation Information: J Clin Invest. 2004;114(1):5-14. https://doi.org/10.1172/JCI22353.
View: Text | PDF | Corrigendum

Acute renal failure: definitions, diagnosis, pathogenesis, and therapy

  • Text
  • PDF
Abstract

Acute renal failure (ARF), characterized by sudden loss of the ability of the kidneys to excrete wastes, concentrate urine, conserve electrolytes, and maintain fluid balance, is a frequent clinical problem, particularly in the intensive care unit, where it is associated with a mortality of between 50% and 80%. In this review, the epidemiology and pathophysiology of ARF are discussed, including the vascular, tubular, and inflammatory perturbations. The clinical evaluation of ARF and implications for potential future therapies to decrease the high mortality are described.

Authors

Robert W. Schrier, Wei Wang, Brian Poole, Amit Mitra

×

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Brian J. Nickoloff, Frank O. Nestle
Brian J. Nickoloff, Frank O. Nestle
Published June 15, 2004
Citation Information: J Clin Invest. 2004;113(12):1664-1675. https://doi.org/10.1172/JCI22147.
View: Text | PDF

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

  • Text
  • PDF
Abstract

Chronic and excessive inflammation in skin and joints causes significant morbidity in psoriasis patients. As a prevalent T lymphocyte–mediated disorder, psoriasis, as well as the side effects associated with its treatment, affects patients globally. In this review, recent progress is discussed in the areas of genetics, the immunological synapse, the untangling of the cytokine web and signaling pathways, xenotransplantation models, and the growing use of selectively targeted therapies. Since psoriasis is currently incurable, new management strategies are proposed to replace previous serendipitous approaches. Such strategic transition from serendipity to the use of novel selective agents aimed at defined targets in psoriatic lesions is moving rapidly from research benches to the bedsides of patients with this chronic and debilitating disease.

Authors

Brian J. Nickoloff, Frank O. Nestle

×

Salt handling and hypertension
Kevin M. O’Shaughnessy, Fiona E. Karet
Kevin M. O’Shaughnessy, Fiona E. Karet
Published April 15, 2004
Citation Information: J Clin Invest. 2004;113(8):1075-1081. https://doi.org/10.1172/JCI21560.
View: Text | PDF

Salt handling and hypertension

  • Text
  • PDF
Abstract

The kidney plays a central role in our ability to maintain appropriate sodium balance, which is critical to determination of blood pressure. In this review we outline current knowledge of renal salt handling at the molecular level, and, given that Westernized societies consume more salt than is required for normal physiology, we examine evidence that the lowering of salt intake can combat hypertension.

Authors

Kevin M. O’Shaughnessy, Fiona E. Karet

×

Multiple sclerosis
David A. Hafler
David A. Hafler
Published March 15, 2004
Citation Information: J Clin Invest. 2004;113(6):788-794. https://doi.org/10.1172/JCI21357.
View: Text | PDF | Erratum

Multiple sclerosis

  • Text
  • PDF
Abstract

Multiple sclerosis is a complex genetic disease associated with inflammation in the CNS white matter thought to be mediated by autoreactive T cells. Clonal expansion of B cells, their antibody products, and T cells, hallmarks of inflammation in the CNS, are found in MS. This review discusses new methods to define the molecular pathology of human disease with high-throughput examination of germline DNA haplotypes, RNA expression, and protein structures that will allow the generation of a new series of hypotheses that can be tested to develop better understanding of and therapies for this disease.

Authors

David A. Hafler

×

New insights into atopic dermatitis
Donald Y.M. Leung, … , Ichiro Nomura, Qutayba A. Hamid
Donald Y.M. Leung, … , Ichiro Nomura, Qutayba A. Hamid
Published March 1, 2004
Citation Information: J Clin Invest. 2004;113(5):651-657. https://doi.org/10.1172/JCI21060.
View: Text | PDF | Erratum

New insights into atopic dermatitis

  • Text
  • PDF
Abstract

Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers and is often the first step in the atopic march that results in asthma and allergic rhinitis. The clinical phenotype that characterizes atopic dermatitis is the product of interactions between susceptibility genes, the environment, defective skin barrier function, and immunologic responses. This review summarizes recent progress in our understanding of the pathophysiology of atopic dermatitis and the implications for new management strategies.

Authors

Donald Y.M. Leung, Mark Boguniewicz, Michael D. Howell, Ichiro Nomura, Qutayba A. Hamid

×

Human African trypanosomiasis of the CNS: current issues and challenges
Peter G.E. Kennedy
Peter G.E. Kennedy
Published February 15, 2004
Citation Information: J Clin Invest. 2004;113(4):496-504. https://doi.org/10.1172/JCI21052.
View: Text | PDF

Human African trypanosomiasis of the CNS: current issues and challenges

  • Text
  • PDF
Abstract

Human African trypanosomiasis (HAT), also known as sleeping sickness, is a major cause of mortality and morbidity in sub-Saharan Africa. Current therapy with melarsoprol for CNS HAT has unacceptable side-effects with an overall mortality of 5%. This review discusses the issues of diagnosis and staging of CNS disease, its neuropathogenesis, and the possibility of new therapies for treating late-stage disease.

Authors

Peter G.E. Kennedy

×

Helicobacter pylori persistence: biology and disease
Martin J. Blaser, John C. Atherton
Martin J. Blaser, John C. Atherton
Published February 1, 2004
Citation Information: J Clin Invest. 2004;113(3):321-333. https://doi.org/10.1172/JCI20925.
View: Text | PDF

Helicobacter pylori persistence: biology and disease

  • Text
  • PDF
Abstract

Helicobacter pylori are bacteria that have coevolved with humans to be transmitted from person to person and to persistently colonize the stomach. Their population structure is a model for the ecology of the indigenous microbiota. A well-choreographed equilibrium between bacterial effectors and host responses permits microbial persistence and health of the host but confers risk of serious diseases, including peptic ulceration and gastric neoplasia.

Authors

Martin J. Blaser, John C. Atherton

×

Disorders of lung matrix remodeling
Harold A. Chapman
Harold A. Chapman
Published January 15, 2004
Citation Information: J Clin Invest. 2004;113(2):148-157. https://doi.org/10.1172/JCI20729.
View: Text | PDF

Disorders of lung matrix remodeling

  • Text
  • PDF
Abstract

A set of lung diseases share the tendency for the development of progressive fibrosis ultimately leading to respiratory failure. This review examines the common pathogenetic features of these disorders in light of recent observations in both humans and animal models of disease, which reveal important pathways of lung matrix remodeling.

Authors

Harold A. Chapman

×
  • ← Previous
  • 1
  • 2
  • …
  • 10
  • 11
  • 12
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts